Send this to a friend

Oxford Immunotec marks 20% growth for 13th straight year

New year, same story for Oxford Immunotec.
The Marlborough medical diagnostics company hit 20-percent year-to-year revenue growth for the 13th consecutive year in 2017, it announced Thursday.
Revenue for the year grew by exactly 20 percent to $103 million. For the fourth quarter, revenue grew slower, by just 6 percent, hitting $25 million.
Bottom-line losses continue for Oxford ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media